Group 1 - The meeting of the Supervisory Board of Fujian Wancheng Biotechnology Group Co., Ltd. was held on September 2, 2025, with all three participating supervisors present [1][2] - The Supervisory Board approved the report on the use of previously raised funds, which was prepared in accordance with regulations for the issuance of overseas listed foreign shares (H shares) [1][2] - The report on the use of funds was verified by Zhongshun Zhonghuan Accounting Firm as of June 30, 2025 [1] Group 2 - The Supervisory Board also approved the establishment of a "External Donation Management System" to enhance corporate governance and promote standardized operations [2] - Both resolutions require submission to the shareholders' meeting for further approval [2]
万辰集团: 第四届监事会第三十三次会议决议公告